Natco Claims Sole Exclusivity For Ibrutinib Tablets

Claims US 180-Day Exclusivity On Four Strengths Of Imbruvica Rival

 
• By David Wallace
  
Natco Pharma Magnifying Glass
Natco says it will be entitled to 180-day exclusivity for four strengths • Source: Alamy

More from Generics

More from Products